Complement component 3d (C3d)

Complement component 3d (C3d) is a 34 kDa proteolytic fragment of the alpha chain of complement component 3 (C3), generated during the final stages of complement activation. It remains covalently attached to cell surfaces or immune complexes via a thioester bond, serving as a durable marker of local complement activation and inflammation. C3d plays a critical role in the adaptive immune response by binding to complement receptor 2 (CR2/CD21) on B cells and follicular dendritic cells, which significantly lowers the threshold for B-cell activation and enhances antigen presentation. In disease states, dysregulated C3d deposition is associated with autoimmune conditions like systemic lupus erythematosus and rheumatoid arthritis, as well as antibody-mediated transplant rejection. Because of its tissue-bound nature, C3d is increasingly utilized as a "molecular zip code" for the delivery of targeted therapeutics, such as fusion proteins that localize complement inhibitors to sites of injury while sparing systemic complement activity. This targeted approach aims to reduce the risk of systemic infections associated with broad complement blockade. Additionally, C3d is being explored as a molecular adjuvant in vaccine development to enhance the immunogenicity of weak antigens.

Other names

Complement C3dComplement 3dComplement C3d fragmentFragment d of complement component 3C3dg (precursor)iC3b (precursor)

Targeted complement inhibition (via C3d-binding fusion proteins that deliver regulatory factors like Factor H to sites of injury) and molecular adjuvant activity (via antigen-C3d fusions that co-engage the B-cell receptor and CR2).